Gene · 1844
Papers2,214
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,214
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA sequencing reveals immunological link between house dust mite allergy and childhood asthma. | Sci Rep | 2025 | 40368964 | PubTator, text mining | PubMed |
| Differential memory enrichment of cytotoxic CD4 T cells in Parkinson's disease patients reactive to α-synuclein. | NPJ Parkinsons Dis | 2025 | 40368950 | PubTator, text mining | PubMed |
| PP1A Modulates the Efficacy of Lenvatinib Plus ICIs Therapy by Inhibiting Ferroptosis in Hepatocellular Carcinoma. | Adv Sci (Weinh) | 2025 | 40344394 | PubTator, text mining | PubMed |
The Reactive Oxygen Species Scavenger N-Acetyl-L-Cysteine Reduces Storage-Dependent Decline in Integrin α IIb β 3-Mediated Platelet Function, Inhibiting Pre-Activation of Integrin and Its β 3 Subunit Cleavage. | Oxid Med Cell Longev | 2025 | 40321407 | PubTator, text mining | PubMed |
| Oxygen Concentration Plays a Critical Role in Fibrinogen-Mediated Platelet Activation via Inactivation of αIIbβ3 and Modulation of Fibrinogen. | Biomolecules | 2025 | 40305211 | PubTator, text mining | PubMed |
| Insulin resistance in type 1 diabetes is a key modulator of platelet hyperreactivity. | Diabetologia | 2025 | 40304758 | PubTator, text mining | PubMed |
| NELFCD Promotes Colon Cancer Progression by Regulating the DUSP2-p38 Axis. | Front Biosci (Landmark Ed) | 2025 | 40302325 | PubTator, text mining | PubMed |
| Effect of Tofacitinib on Hemostasis in Patients with Ulcerative Colitis: A Comparative Ex Vivo Study. | Pharmaceuticals (Basel) | 2025 | 40283992 | PubTator, text mining | PubMed |
| PAC-1 Synergizes with Sunitinib to Enhance Cell Death in Pancreatic Neuroendocrine Tumors. | ACS Pharmacol Transl Sci | 2025 | 40242587 | PubTator, text mining | PubMed |
| Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma. | Transl Oncol | 2025 | 40014976 | PubTator, text mining | PubMed |
| Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency. | Res Pract Thromb Haemost | 2025 | 39995753 | PubTator, text mining | PubMed |
| PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1/2 in hepatocellular carcinoma. | J Biol Chem | 2025 | 39993527 | PubTator, text mining | PubMed |
| Single cell transcriptomics in blood of patients with chronic obstructive pulmonary disease. | BMC Pulm Med | 2025 | 39810158 | PubTator, text mining | PubMed |
| Roles of ROCK/Myosin Pathway in Macrothrombocytopenia in Bernard-Soulier Syndrome. | Thromb Haemost | 2025 | 39694061 | PubTator, text mining | PubMed |
| Human B-cells can form Hetero-aggregates with Blood Platelets: A Novel Insight into Adaptive Immunity Regulation in Multiple Sclerosis. | J Mol Biol | 2025 | 39613182 | PubTator, text mining | PubMed |
| PEGylated Titanium Dioxide Nanoparticle-bound Doxorubicin and Paclitaxel Drugs Affect Prostate Cancer Cells and Alter the Expression of DUSP Family Genes. | Anticancer Agents Med Chem | 2025 | 39473102 | PubTator, text mining | PubMed |
| Transcription Factor RUNX1 Regulates Coagulation Factor XIII-A ( F13A1 ): Decreased Platelet-Megakaryocyte F13A1 Expression and Clot Contraction in RUNX1 Haplodeficiency. | medRxiv | 2024 | 39763522 | PubTator, text mining | PubMed |
| Role of Protein Tyrosine Phosphatases in Inflammatory Bowel Disease, Celiac Disease and Diabetes: Focus on the Intestinal Mucosa. | Cells | 2024 | 39682729 | PubTator, text mining | PubMed |
| Cnaphalocrocis medinalis granulovirus regulates apoptosis by targeting AIF1 and ASPP1 through tca-miR-3885-5p and tca-miR-3897-3p to promote infection. | Pestic Biochem Physiol | 2024 | 39672625 | PubTator, text mining | PubMed |
| Absence of platelet overactivation and thrombosis formation among patients with coronary atherosclerosis disease after vaccination against SARS-CoV-2. | Heliyon | 2024 | 39640769 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1844/papers?page=5